Mersana Therapeutics, Inc. (MRSN) has a market capitalization of $145.36M and trades at $29.08. The 52-week range is 5.21-30.39.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -51.9, Earnings Per Share (EPS) of $-0.56, annual revenue of $40.5M.
The stock has a beta of 0.43, operates in the Healthcare sector.
